McKesson

YTD

ALL

Trade McKesson 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About MCK

McKesson Corp. engages in providing healthcare services. It operates through the following segments: North American Pharmaceutical, Oncology and Multispecialty, Prescription Technology Solutions (RxTS), and Medical-Surgical Solutions.

CEO

Brian Scott Tyler

CEOBrian Scott Tyler

Employees

43,000

Employees43,000

Headquarters

Irving, Texas

HeadquartersIrving, Texas

Founded

1833

Founded1833

Employees

43,000

Employees43,000

MCK Key Statistics

Market cap

91.42B

Market cap91.42B

Price-Earnings ratio

19.82

Price-Earnings ratio19.82

Dividend yield

0.42%

Dividend yield0.42%

Average volume

1.49M

Average volume1.49M

High today

$765.90

High today$765.90

Low today

$750.15

Low today$750.15

Open price

$754.25

Open price$754.25

Volume

1.53M

Volume1.53M

52 Week high

$999.00

52 Week high$999.00

52 Week low

$637.00

52 Week low$637.00

Stock Snapshot

With a market cap of 91.42B, McKesson(MCK) trades at $760.57. The stock has a price-to-earnings ratio of 19.82 and currently yields dividends of 41.7%.

During the trading session on 2026-05-17, McKesson(MCK) shares reached a daily high of $765.90 and a low of $750.15. At a current price of $760.57, the stock is +1.4% higher than the low and still -0.7% under the high.

Trading activity shows a volume of 1.53M, compared to an average daily volume of 1.49M.

The stock's 52-week range extends from a low of $637.00 to a high of $999.00.

MCK News

MarketWatch 2d

McKesson Corp. stock outperforms competitors on strong trading day - MarketWatch

...

TipRanks 2d

Erin Wright Reiterates Buy on McKesson, Citing Durable Growth, Biosimilar Tailwinds, and AI-Driven Efficiency Supporting Higher FY27 Valuation Multiple

Erin Wright, an analyst from Morgan Stanley, reiterated the Buy rating on McKesson. The associated price target is $966.00. Unlock hedge fund-level data and po...

TipRanks 3d

McKesson price target lowered to $945 from $975 at Citi

Citi lowered the firm’s price target on McKesson (MCK) to $945 from $975 and keeps a Buy rating on the shares. Unlock hedge fund-level data and powerful invest...

Analyst ratings

86%

of 21 ratings

Buy

85.7%

Hold

9.5%

Sell

4.8%

More MCK News

Simply Wall St 4d

Medical-Surgical Spinoff and Buybacks Could Be A Game Changer For McKesson

McKesson Corporation recently reported its fourth-quarter and fiscal 2026 results, with quarterly sales of US$96,295 million and net income of US$1,682 million,...

Nasdaq 6d

McKesson Q4 Earnings Call Highlights

McKesson (NYSE:MCK) reported a stronger fiscal fourth quarter and full fiscal 2026 performance, with executives pointing to growth across its oncology, multispe...

People also own

Based on the portfolios of people who own MCK. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.